Senseonics Holdings, Inc. (SENS) Social Stream

Senseonics Holdings, Inc. (SENS): $3.12

0.05 (+1.63%)

POWR Rating

Component Grades













Featured Post From StockTwits About SENS

$SENS Today, CGM market leader DXCM breaks $500. DXCM is a great company and has a nice product.
For those SENS share holder, we hope SENS can copy DXCM story. compare to DXCM,SENS has a very different product, I think the market does need two kinds of CGM . Let's hope SENS become the same size or even bigger company than DXCM. most importent, believe SENS, HOLD YOUR SHARES!
Remember Nokia and Blackberry were the smart phone market leaders, but Apple took over in 3 years. Can SENS follow such great success, I think it can and we Longs will be rich 🤑
StocksAndLuck, published August 1, 2021

What Else are SENS Traders Talking About?

Other tickers frequently mentioned alongside SENS are ITUB, ABEV and OXY.

Other Notable StockTweets About SENS

$SENS While I can appreciate everyone's hostile comments- the Acenscia deal simply can not be overlooked. As stated they can pull out on August 31 if no FDA approval by then. True #SENS has a 180 day monitor which was already approved and is selling in Europe. So I'm not saying it is not an excellent and very beneficial product. But look at revenue-not sales-revenue. It is down 500% ytd. Ascencia can pull out and renegotiate (if they choose to) on Sept 1. What company wouldn't do that-taking advantage of the contract to make a better deal for themselves going forward. Not saying it will happen-just saying I would wait until AFTER Aug 31 to invest..Peace

BlameTheBartender, published July 28, 2021

$SENS [Still True] Earnings are set here for 8/09, and I see a similar situation to the last earnings periods - a run down on the stock ahead of the earnings call. Honestly-look at the charts, and you will see a run down in February ahead of 3/04 earnings, a similar move in April ahead of 5/13, and now a downward pull in July ahead of 8/09. I still hold a larger position in the Company - sold off a little at/around $3.70, and continue buying back into a larger position at/under $3.00. Progress on the 180day CGM (FDA approval pending) and perhaps some material improvement on the balance sheet and/or income statement should provide support to the continued progress here to fair value.

BinaryLogic, published July 23, 2021

$SENS I'm surprised Institutional investors and funds aren't loading up on this, but not exactly how they determine what/when to buy, but at some point it seems like heavy buying should occur! Approval come ould early and those holding when it does SENS could BLOW up to 10.00 or more almost overnight because their device is a game changer in the diabetes world. I'd love to buy as much as possible but lack of funds.

ChunkyG, published July 13, 2021

$ITUB $ABEV $OXY $DMYQ $SENS Guys, i've made $1800 into $40k in the last 30 days.... If you really want to make huge profits for a limited time trading then,,. Join this winning chat !!

TraceyStrickland, published July 7, 2021

Loading social stream, please wait...

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.532 seconds.